
What We’re Reading: Omicron Wave Expected in January; Pfizer COVID-19 Pill Effective vs Variant; JP Morgan Conference Moves Virtual
The Omicron variant may cause a wave of infections as soon as January 2022; Pfizer’s COVID-19 pill, Paxlovid, was found to reduce the risk of hospitalization and death by 88%; JPMorgan Health Care Conference will move to a virtual format after receiving pressure from major drug companies.
CDC Data Predict Omicron Wave as Soon as January
Based on data from the CDC, US federal health officials warned that the Omicron variant of COVID-19 is spreading rapidly across the country and may cause a wave of infections as soon as January,
Pfizer COVID-19 Pill Likely to Work Against Omicron
The Pfizer COVID-19 pill sold as Paxlovid is likely to be an effective treatment against the Omicron variant and could be available in the United States before 2022,
JPMorgan Health Care Conference Changed to Virtual Format
Biotech’s biggest annual conference, the JPMorgan Health Care Conference, moved to a virtual format after receiving pressure from major drug companies,
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.